Qsemble Capital Management, LP Revolution Medicines, Inc. Transaction History
Qsemble Capital Management, LP
- $941 Billion
- Q1 2025
A detailed history of Qsemble Capital Management, LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Qsemble Capital Management, LP holds 11,195 shares of RVMD stock, worth $433,694. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,195Holding current value
$433,694% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$644 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$524 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$519 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$457 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$395 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.4B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...